These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37956384)

  • 1. HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women.
    Nguyen MN; Nguyen TTH; Pham TDH; Khuu VN; Hoang QC; Nguyen VT; Tran NH
    J Infect Dev Ctries; 2023 Oct; 17(10):1489-1492. PubMed ID: 37956384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 3. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
    Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
    J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.
    Samadi Kochaksaraei G; Congly SE; Matwiy T; Castillo E; Martin SR; Charlton CL; Coffin CS
    Liver Int; 2016 Nov; 36(11):1604-1610. PubMed ID: 27059287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
    Boucheron P; Lu Y; Yoshida K; Zhao T; Funk AL; Lunel-Fabiani F; Guingané A; Tuaillon E; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):85-96. PubMed ID: 32805201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
    Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study.
    Ségéral O; N'Diaye DS; Prak S; Nouhin J; Chhun S; Khamduang W; Chim K; Roque-Afonso AM; Piola P; Borand L; Ngo-Giang-Huong N; Rouet F;
    J Clin Virol; 2018 Dec; 109():29-34. PubMed ID: 30388664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
    Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
    World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B e Antigen (HBeAg) Rapid Test and Alanine Aminotransferase Level-Based Algorithm to Identify Pregnant Women at Risk of HBV Mother-to-Child Transmission: The ANRS 12345 TA PROHM Study.
    Segeral O; Dim B; Durier C; Prak S; Chhim K; Vong C; Pech S; Tiv S; Nem B; Hout K; Nouhin J; Chhun S; Borand L
    Clin Infect Dis; 2020 Dec; 71(10):e587-e593. PubMed ID: 32188982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria.
    Ndububa D; Kuti O; Awowole I; Adekanle O; Ijarotimi O; Makinde O; Adeyemi A; Anyabolu C; Ijadunola M
    BMJ Open; 2022 Nov; 12(11):e063482. PubMed ID: 36351715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate.
    Chang HL; Wen WH; Lee CN; Chiu YE; Liu CJ; Chang MH; Lin LH; Chen HL
    J Viral Hepat; 2022 Feb; 29(2):107-114. PubMed ID: 34724288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HBV-DNA and HBeAg as antiviral therapeutic indicators among HBV-infected pregnant women: a systematic review and meta-analysis.
    Liu X; Chen C; Jiang D; Cui D; Yan D; Zhou Y; Ding C; Lan L; Huang C; Zhang X; Li L; Zhu C; Yang S
    Ann Palliat Med; 2021 Sep; 10(9):9362-9371. PubMed ID: 34379980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China.
    Chen T; Wang J; Qiu H; Yu Q; Yan T; Qi C; Cao F; Tian Z; Guo D; Yao N; Yang Y; He Y; Zhao Y; Liu J
    Medicine (Baltimore); 2018 Jul; 97(27):e11406. PubMed ID: 29979437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy: Insights from a multi-ethnic cohort.
    Mak LY; Koffas A; Dolman GE; Saleh H; Kemos P; Riddell A; Gill U; Kennedy PTF
    J Viral Hepat; 2024 Jan; 31(1):3-11. PubMed ID: 37881873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North America.
    Samadi Kochaksaraei G; Castillo E; Sadler MD; Seow CH; Barkema HW; Martin SR; Israelson H; Pinto J; Williams S; Aspinall AI; Stinton LM; Borman MA; Burak KW; Swain MG; Congly SE; Lee SS; Shaheen AA; Coffin CS
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1707-1716. PubMed ID: 33111382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.